Cannara Biotech Inc. (TSXV:LOVE)
Canada
· Delayed Price · Currency is CAD 1.900
-0.010 (-0.52%)
Aug 14, 2025, 10:00 AM EDT
Cannara Biotech Revenue
Cannara Biotech had revenue of 27.27M CAD in the quarter ending May 31, 2025, with 40.01% growth. This brings the company's revenue in the last twelve months to 101.87M, up 33.09% year-over-year. In the fiscal year ending August 31, 2024, Cannara Biotech had annual revenue of 81.75M with 42.77% growth.
Revenue (ttm)
101.87M
Revenue Growth
+33.09%
P/S Ratio
1.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
174.64M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.75B |
| Green Thumb Industries | 1.57B |
| Trulieve Cannabis | 1.62B |
| Sienna Senior Living | 929.68M |
| dentalcorp Holdings | 1.62B |
| Cronos Group | 177.69M |
| WELL Health Technologies | 990.34M |
| Extendicare | 1.51B |